EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Treatment trajectories and outcomes in inflammatory bowel disease: a tertiary single-centre experience

Kim Wagner, Tanja M Müller iD, Francesco Vitali, Sarah Fischer iD, Sophie Haberkamp, Rachel Rouse-Merkel, Raja Atreya iD, Markus F Neurath, Sebastian Zundler iD

Therapeutic Advances in Gastroenterology · 2024-01 · 17

DOI: 10.1177/17562848241284051 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Advances in Gastroenterology, online erschienen am 28.09.2024. Verfasst von Kim Wagner und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Else Kröner-Fresenius-Stiftung, Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There is an increasing diversification in the treatment landscape for inflammatory bowel diseases (IBD) leading to therapeutic challenges that can only incompletely be covered by prospective randomized double-blind trials. Real-world observations are therefore an important tool to provide insights into therapeutic strategies.

Objectives

To describe the real-world treatment algorithms in an IBD referral centre.

Design

Single-centre retrospective cohort study.

Methods

We retrospectively analysed prospectively collected data on treatment sequences and outcomes from 502 patients with Crohn’s disease (CD) and ulcerative colitis (UC) treated with infliximab, adalimumab, vedolizumab or ustekinumab at a large German tertiary referral centre.

Results

Treatment decisions correlated to baseline patient characteristics. Over time, infliximab continued to be the preferred first-line option in CD and UC, although ustekinumab and vedolizumab, respectively, became increasingly important choices. Remission rates decreased with the advancement of therapy lines.

Conclusion

We provide insights into the evolution of tertiary centre real-world treatment sequences that might – together with other observations – help to guide the selection of therapies in IBD. Our data also strongly underscore the unmet need for biomarkers supporting treatment decisions.

Trial registration

None.

Schlagwörter

Stichwörter der Autor:innen

Crohn’s diseasebiological therapyinflammatory bowel diseasereal-world studytreatment algorithmsulcerative colitis

Autor:innen und Institutionen

  • Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
  • Deutsches Zentrum Immuntherapie (DZI), University Hospital Erlangen, Erlangen, Germany.
  • Department of Medicine 1, Friedrich-Alexander University Erlangen-Nuremberg, Ulmenweg 18, Erlangen, D-91054, Germany.

ORCID-Profile: Tanja M Müller, Sarah Fischer, Raja Atreya, Sebastian Zundler

Förderung

  • Else Kröner-Fresenius-Stiftung
  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Wagner, K., Müller, T. M., Vitali, F., Fischer, S., Haberkamp, S., Rouse-Merkel, R., Atreya, R., Neurath, M. F., & Zundler, S. (2024). Treatment trajectories and outcomes in inflammatory bowel disease: a tertiary single-centre experience. Therapeutic Advances in Gastroenterology, 17. https://doi.org/10.1177/17562848241284051

Vancouver

Wagner K, Müller TM, Vitali F, Fischer S, Haberkamp S, Rouse-Merkel R, et al. Treatment trajectories and outcomes in inflammatory bowel disease: a tertiary single-centre experience. Therapeutic Advances in Gastroenterology. 2024;17. doi:10.1177/17562848241284051

BibTeX
@article{Wagner2024,
  author = {Wagner, Kim and Müller, Tanja M and Vitali, Francesco and Fischer, Sarah and Haberkamp, Sophie and Rouse-Merkel, Rachel and Atreya, Raja and Neurath, Markus F and Zundler, Sebastian},
  title = {Treatment trajectories and outcomes in inflammatory bowel disease: a tertiary single-centre experience},
  journal = {Therapeutic Advances in Gastroenterology},
  year = {2024},
  volume = {17},
  doi = {10.1177/17562848241284051}
}
Kostenlos starten →